-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ulixacaltamide Hydrochloride in Essential Tremor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ulixacaltamide Hydrochloride in Essential Tremor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ulixacaltamide Hydrochloride in Essential Tremor Drug Details: Ulixacaltamide hydrochloride (PRAX-944)...
-
Product Insights
Tremor – Drugs In Development, 2023
Global Markets Direct’s, ‘Tremor - Drugs In Development, 2023’, provides an overview of the Tremor pipeline landscape. The report provides comprehensive information on the therapeutics under development for Tremor, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Essential Tremor – Drugs In Development, 2023
Global Markets Direct’s, ‘Essential Tremor - Drugs In Development, 2023’, provides an overview of the Essential Tremor pipeline landscape. The report provides comprehensive information on the therapeutics under development for Essential Tremor, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Brexanolone in Essential Tremor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Brexanolone in Essential Tremor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Brexanolone in Essential Tremor Drug Details: Brexanolone is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ulixacaltamide in Essential Tremor
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Ulixacaltamide in Essential Tremor Drug Details: Ulixacaltamide (PRAX-944) is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval Analysis for Pheochromocytoma
Overview How likely is it that the drugs in Pheochromocytoma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pheochromocytoma Overview Pheochromocytoma is a rare, usually non-cancerous (benign) tumor that develops from...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Suvecaltamide Hydrochloride in Myoclonic Seizure
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Suvecaltamide Hydrochloride in Myoclonic Seizure report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Suvecaltamide Hydrochloride in Myoclonic Seizure Drug Details: JZP-385 (CX-8998) is under...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Suvecaltamide Hydrochloride in Absence Seizure
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Suvecaltamide Hydrochloride in Absence Seizure report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Suvecaltamide Hydrochloride in Absence Seizure Drug Details: JZP-385 (CX-8998) is under...
-
Company Insights
Innovation and Patenting activity of Tremor International Ltd Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Tremor International Ltd Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Onabotulinumtoxin A in Essential Tremor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Onabotulinumtoxin A in Essential Tremor report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Onabotulinumtoxin A in Essential Tremor Drug Details: Onabotulinumtoxin A (Botox /...